Literature DB >> 2350097

Cellularity of the alveolar walls in smokers and its relation to alveolar destruction. Functional implications.

D Eidelman1, M P Saetta, H Ghezzo, N S Wang, J R Hoidal, M King, M G Cosio.   

Abstract

Inflammatory cells are believed to play an important role in the pathogenesis of emphysema; however, a relationship between presence of cells in the lung parenchyma and its destruction has never been shown. The aim of this study was to quantitate alveolar septal cellularity in smokers' lungs and to investigate its relationship with parenchymal destruction and lung function. The lungs of 23 smokers (SS) undergoing thoracotomy for localized pulmonary lesions were compared with those of eight nonsmokers (NS) and five smokers (AS) who died suddenly of nonrespiratory causes. Pulmonary function tests were performed within 1 wk of surgery in SS. For each subject, we quantitated alveolar wall cells (CELLS), an index of alveolar wall destruction (DI), and the mean linear intercept (Lm). As no significant differences were found between S and AS with regard to these indices, we combined them (Group S) for comparison with NS. Although Lm was not significantly different between S and NS, (0.331 +/- 0.072 versus 0.288 +/- 0.038), CELLS and DI were higher in S than in NS (48 +/- 8 versus 25 +/- 2 cells/mm, p less than 0.001; 47 +/- 20 versus 17 +/- 5, p less than 0.001, respectively). Further, CELLS and DI were significantly correlated (r = 0.799, p less than 0.001). The number of polymorphonuclear cells (PMN) in S can exceed that in NS by as much as 5-fold; however, PMN were inversely correlated with parenchymal destruction (DI) (r = 0.598, p less than 0.01). Thus, smokers' lungs have alveolar septal hypercellularity, possibly inflammatory, and closely related to destruction involving cells other than the PMN.

Entities:  

Mesh:

Year:  1990        PMID: 2350097     DOI: 10.1164/ajrccm/141.6.1547

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  15 in total

1.  Prevention of lung injury by Muc1 mucin in a mouse model of repetitive Pseudomonas aeruginosa infection.

Authors:  Tsuyoshi Umehara; Kosuke Kato; Yong Sung Park; Erik P Lillehoj; Hideyuki Kawauchi; Kwang Chul Kim
Journal:  Inflamm Res       Date:  2012-05-29       Impact factor: 4.575

Review 2.  Matrix metalloproteinases in emphysema.

Authors:  Sina A Gharib; Anne M Manicone; William C Parks
Journal:  Matrix Biol       Date:  2018-03-23       Impact factor: 11.583

3.  Theoretical diagnosis of emphysema by aerosol bolus inhalation.

Authors:  Robert Sturm
Journal:  Ann Transl Med       Date:  2017-04

4.  Chronic obstructive pulmonary disease: role of bronchiolar mast cells and macrophages.

Authors:  W F Grashoff; J K Sont; P J Sterk; P S Hiemstra; W I de Boer; J Stolk; J Han; J M van Krieken
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

Review 5.  Imaging of macrophage-related lung diseases.

Authors:  Katharina Marten; David M Hansell
Journal:  Eur Radiol       Date:  2005-01-05       Impact factor: 5.315

Review 6.  Impact of smoking on asthma therapy: a critical review of clinical evidence.

Authors:  Eric Livingston; Neil C Thomson; George W Chalmers
Journal:  Drugs       Date:  2005       Impact factor: 9.546

7.  Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice.

Authors:  Steven D Shapiro; Nir M Goldstein; A McGarry Houghton; Dale K Kobayashi; Diane Kelley; Abderazzaq Belaaouaj
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

Review 8.  Molecular pathogenesis of emphysema.

Authors:  Laimute Taraseviciene-Stewart; Norbert F Voelkel
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

Review 9.  Environmental and genetic risk factors and gene-environment interactions in the pathogenesis of chronic obstructive lung disease.

Authors:  R Walter; D J Gottlieb; G T O'Connor
Journal:  Environ Health Perspect       Date:  2000-08       Impact factor: 9.031

10.  Patterns of airway inflammation and MMP-12 expression in smokers and ex-smokers with COPD.

Authors:  Agne Babusyte; Kristina Stravinskaite; Jolanta Jeroch; Jan Lötvall; Raimundas Sakalauskas; Brigita Sitkauskiene
Journal:  Respir Res       Date:  2007-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.